⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Official Title: Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Control Subjects From the Primary NCT00294047 Study

Study ID: NCT01190189

Study Description

Brief Summary: This extension study is designed to assess the safety of GSK Biological's human papillomavirus (HPV) vaccine GSK580299 in female subjects who took part in the primary study NCT00294047 and received the control vaccine in countries for which the licensed GSK HPV vaccine is not indicated for the subject's age group (26 years and older). This study is thus conducted to enable all women who received the control placebo in the primary NCT00294047 study to receive the GSK580299 vaccine.

Detailed Description: This Protocol Posting has been updated following Protocol Amendment 1, December 2010, leading to the update of 1 of the primary outcome measures and following Protocol Amendment 2, January 2011, leading to the removal of one of the exclusion criteria.

Eligibility

Minimum Age: 26 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: Yes

Locations

GSK Investigational Site, Aurora, Colorado, United States

GSK Investigational Site, Golden, Colorado, United States

GSK Investigational Site, Coral Gables, Florida, United States

GSK Investigational Site, Miami, Florida, United States

GSK Investigational Site, Augusta, Georgia, United States

GSK Investigational Site, Iowa City, Iowa, United States

GSK Investigational Site, Wichita, Kansas, United States

GSK Investigational Site, Bardstown, Kentucky, United States

GSK Investigational Site, Louisville, Kentucky, United States

GSK Investigational Site, Omaha, Nebraska, United States

GSK Investigational Site, Lebanon, New Hampshire, United States

GSK Investigational Site, New Bern, North Carolina, United States

GSK Investigational Site, Cleveland, Ohio, United States

GSK Investigational Site, Carnegie, Pennsylvania, United States

GSK Investigational Site, Erie, Pennsylvania, United States

GSK Investigational Site, Erie, Pennsylvania, United States

GSK Investigational Site, Pittsburgh, Pennsylvania, United States

GSK Investigational Site, Houston, Texas, United States

GSK Investigational Site, Salt Lake City, Utah, United States

GSK Investigational Site, Salt Lake City, Utah, United States

GSK Investigational Site, Wenatchee, Washington, United States

GSK Investigational Site, Edmonton, Alberta, Canada

GSK Investigational Site, Vancouver, British Columbia, Canada

GSK Investigational Site, Halifax, Nova Scotia, Canada

GSK Investigational Site, Truro, Nova Scotia, Canada

GSK Investigational Site, Waterloo, Ontario, Canada

GSK Investigational Site, Sherbrooke, Quebec, Canada

GSK Investigational Site, Quebec, , Canada

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: